IL-37 过表达通过激活自噬并改善皮肤屏障功能,增强脂肪源性间充质干细胞对特应性皮炎的治疗效果。
IL-37 overexpression enhances the therapeutic efficacy of adipose-derived mesenchymal stem cells in atopic dermatitis by activating autophagy and improving skin barrier dysfunction
Wenjing Chen, Shuyan Li, Xiaoping Guo, Fengxia Hu, Qian Wang, Xiaoyu Zhang, Fuyang Xiao, Jinying Zhang, Junqin Liang
Journal:JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
IF:4.3
DOI:10.1016/j.jpet.2026.105032
PMID:42880197
Published:2026-09-21
research field:分子生物学皮肤病学免疫调节干细胞治疗
Abstract
Adipose-derived mesenchymal stem cells (ADSCs) have emerged as a promising therapeutic option due to their immunomodulatory and tissue-repair capabilities in the treatment of Atopic dermatitis (AD). However, their efficacy is limited by cellular senescence and functional decline. Interleukin-37 (IL-37), an anti-inflammatory cytokine, has shown potential in mitigating inflammation and enhancing skin barrier function. This study investigated whether IL-37 overexpression in ADSCs could augment their therapeutic effects in AD and the underlying mechanism. Lentiviral-mediated IL-37 overexpression in ADSCs enhanced proliferation, reduced senescence (evidenced by decreased β-galactosidase activity), and activated autophagy, as shown by elevated LC3B-II/I and Beclin-1 levels, reduced p62, and increased LC3B puncta formation. These effects were reversed by the autophagy inhibitor 3-MA. In an IL-4/IL-13-induced HaCaT cell model of AD, co-culture with IL-37-overexpressing ADSCs (ADSCs-IL-37-OE) promoted keratinocyte proliferation, reduced apoptosis, suppressed pro-inflammatory cytokines (IL-1β, IL-6, TNF-α, TARC), and restored the expression of skin barrier proteins (filaggrin, involucrin). In vivo , local injection of ADSCs-IL-37-OE into lesional skin in a DNCB-induced AD mouse model attenuated skin lesions, reduced inflammation, and improved barrier protein expression. These results demonstrate that IL-37 overexpression enhances the therapeutic efficacy of ADSCs in AD through autophagy activation and restoration of skin barrier function, providing a novel genetically engineered stem cell-based strategy for the treatment of AD. Download: Download high-res image (123KB) Download: Download full-size image
本文使用的Yeasen产品
南美超级胎牛血清999尝鲜特惠


